wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27010542-44A1136C-D4BF-4DA1-B43C-CAC6DE58CBF0
Q27010542-44A1136C-D4BF-4DA1-B43C-CAC6DE58CBF0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27010542-44A1136C-D4BF-4DA1-B43C-CAC6DE58CBF0
Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer
P2860
Q27010542-44A1136C-D4BF-4DA1-B43C-CAC6DE58CBF0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27010542-44A1136C-D4BF-4DA1-B43C-CAC6DE58CBF0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
43c61772de0d2de8d008c61ea1b58aac01b3000c
P2860
Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.